ConforMIS, Inc. (NASDAQ:CFMS) will be discussing 3Q20 financial results with the investment community.on 4th November 2020 at 4:30 PM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.conformis.com
Earnings Expectation
ConforMIS, Inc. is expected to report third quarter earnings results, after market close, on Wednesday 4th November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.12 per share from revenue of $ 14.42 million. Looking ahead, the full year loss are expected at $ 0.38 per share on the revenues of $ 70.77 million.
The Company Outlook
Revenue for 3Q20 are expected in a range of $ 16.10 million ~ $ 16.10 million
Click Here For More Historical Outlooks Of ConforMIS, Inc.
Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a customized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee. It also provides Conformis Hip System, a hip replacement product; and iJigs, a customized single-use patient-specific instrumentation.
